Detection of dose response in chronic doxorubicin-mediated cell death with cardiac technetium 99m annexin v single-photon emission computed tomography

Molecular Imaging

Volumn 7, Issue 3, 2008, Pages 132-138

  Gabrielson, Kathleen L ^a   Mok, Greta S P ^a   Nimmagadda, Srihdar ^a   Bedja, Djahida ^a   Pin, Scott ^a   Tsao, Allison ^a   Wang, Yuchuan ^a   Sooryakumar, Dhrtti ^a   Yu, S Jianhua ^a   Pomper, Martin G ^a   Tsui, Benjamin M W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT FEMALES; ANNEXIN; BIO DISTRIBUTIONS; CARDIAC IMAGES; CARDIAC TOXICITIES; DOSE DEPENDENTS; DOSE RESPONSE; DOXORUBICIN; DUAL HEADS; IN-VIVO; MOLECULAR IMAGING; MULTIPINHOLE; MYOCARDIAL FUNCTIONS; POSTINJECTION; RECONSTRUCTED IMAGES; REGIONS OF INTERESTS; SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHIES; SMALL ANIMALS; SOFT-TISSUE REGIONS; SPECT/CT; SPRAGUE-DAWLEY RATS; TECHNETIUM-99M; TUNEL ASSAYS;

ANTIBIOTICS; CELL DEATH; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC RADIOGRAPHY; ECHOCARDIOGRAPHY; PARTICLE BEAMS; PHOTONS; RADIOACTIVITY MEASUREMENT; RATS; TECHNETIUM; TOXICITY;

SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

DIAGNOSTIC AGENT; DOXORUBICIN; LIPOCORTIN 5; TECHNETIUM COMPLEX; TECHNETIUM TC 99M HYNIC ANNEXIN V;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; CARDIOVASCULAR SYSTEM EXAMINATION; CELL DEATH; DOSE RESPONSE; DRUG EFFECT; ECHOCARDIOGRAPHY; FEMALE; HEART; HEART MUSCLE; METABOLISM; METHODOLOGY; NICK END LABELING; PATHOLOGY; RANDOMIZATION; RAT; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

ANALYSIS OF VARIANCE; ANIMALS; ANNEXIN A5; CELL DEATH; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; ECHOCARDIOGRAPHY; FEMALE; HEART; IN SITU NICK-END LABELING; MYOCARDIUM; ORGANOTECHNETIUM COMPOUNDS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 61749083033     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2008.00015     Document Type: Article

References (16)

1. Blum RH, Carter SK. Adriamycin. A new anticancer drug with significant clinical activity. Ann Intern Med 1974;80:249-59.
2. Allen A. The cardiotoxicity of chemotherapeutic drugs. Semin Oncol 1992;19:529-42.
3. Bristow MR, Billingham ME, Mason JW, Daniels JR. Clinical spectrum of anthracycline antibiotic cardiotoxicity. Cancer Treat Rep 1978;62:873-9.
4. Mitani I, Jain D, Joska T, et al. Doxorubicin cardiotoxicity: prevention of congestive heart failure with serial cardiac function monitoring with equilibrium radionuclide angiocardiography in the current era. J Nucl Cardiol 2003;10:132-9.
5. Schmitt K, Tulzer G, Merl M, et al. Early detection of doxorubicin and daunorubicin cardiotoxicity by echocardiography: diastolic versus systolic parameters. Eur J Pediatr 1995;154:201-4.
6. Schwartz RG, McKenzie WB, Alexander J, et al. Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography. Am J Med 1987;82:1109-18.
7. Billingham M. Role of endomyocardial biopsy in diagnosis and treatment of heart disease. In Silver MD, editor. Cardiovascular pathology. New York: Churchill Livingstone; 1991. p. 1465-86.
8. Carrio I, Estorch M, Berna L, et al. Indium-111-antimyosin and iodine-123-MIBG studies in early assessment of doxorubicin cardiotoxicity. J Nucl Med 1995;36:2044-9.
9. Korngold EC, Jaffer F, Weissleder R, et al. Noninvasive imaging of apoptosis in cardiovascular disease. Heart Fail Rev 2008;13: 163-73.
10. Gabrielson K, Bedja D, Pin S, et al. Heat shock protein 90 and ErbB2 in the cardiac response to doxorubicin injury. Cancer Res 2007;67:1436-41.
11. Lahorte CM, Vanderheyden J, Steinmetz N, et al. Apoptosis-detecting radioligands: current state of the art and future perspectives. Eur J Nucl Med Mol Imaging 2004;31:887-919.
12. Ng R, Green MD. Managing cardiotoxicity in anthracycline-treated breast cancers. Expert Opin Drug Saf 2007;6:315-21.
13. Bennink RJ, Vandenhoff M, Van Hemert F, et al. Annexin V imaging of acute doxorubicin cardiotoxicity (apoptosis) in rats. J Nucl Med 2004;45:842-8.
14. Schwarz ER, Pollick C, Dow J, et al. A small animal model of nonischemic cardiomyopathy and its evaluation by transthoracic echocardiography. Cardiovasc Res 1998;39:216-23.
15. Beekman FJ, Vander Have F, Vastenhouw B, et al. U-SPECT-I: a novel system for submillimeter-resolution tomography with radiolabeled molecules in mice. J Nucl Med 2005;46:1194-200.
16. Pissarek MB, Oros-Peusquens AM, Schramm NU. Challenge by the murine brain: multi-pinhole SPECT of (123)I-labelled pharmaceuticals. J Neurosci Methods 2008;168:282-92.